HURA
TuHURA Biosciences, Inc.
$1.67
%
Analyst Rating:Buy

Stock Details

CEO

James A. Bianco

Sector

Healthcare

Industry

Biotechnology

Full Time Employees

19

Address

10500 University Center Drive, Tampa

TuHURA Biosciences, Inc. is a phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company is headquartered in Tampa, FL.

Income Statement  

Financials

Selected Year

Revenue Estimates

EPS Estimates

Net Income Estimates

Price target for TuHURA Biosciences, Inc.  $1.67

EPS

Revenue

Congress Tracker 

Insider Trading of Key Employees

Financial News: HURA